Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vermeire

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Journal of Crohn'S & Colitis|January 8, 2014
Genetic susceptibility and genotype-phenotype association in 588 Danish children with inflammatory bowel diseaseC Jakobsen, I Cleynen, P S Andersen, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2013
Letter: dry blood spots for anti-TNF treatment monitoring in IBDN Vande Casteele, S Brecx, P Declerck, et al.
Gastroenterology|March 7, 2001
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosomeS Vermeire, J Satsangi, M Peeters, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2016
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experienceT Billiet, I Cleynen, V Ballet, et al.
The British Journal of Surgery|August 19, 2009
Outcome of surgery for rectovaginal fistula due to Crohn's diseaseC Ruffolo, F Penninckx, G Van Assche, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2011
Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assayN Vande Casteele, C Breynaert, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2004
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximabM Pierik, S Vermeire, K V Steen, et al.
Journal of Crohn'S & Colitis|August 18, 2021
Non-conventional Versus Conventional Strictureplasties for Crohn's Disease. A Systematic Review and Meta-analysis of Treatment OutcomesG Bislenghi, F Sucameli, S Fieuws, et al.
Scandinavian Journal of Gastroenterology|May 13, 2023
Managing metastatic Crohn's disease: a single center experience, review of the current evidence, and treatment algorithmS Beysens, J Wellens, G De Hertogh, et al.
Human Genetics|May 17, 2001
Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel diseaseA Rector, S Vermeire, I Thoelen, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Journal of Crohn'S & Colitis|January 8, 2014
Genetic susceptibility and genotype-phenotype association in 588 Danish children with inflammatory bowel diseaseC Jakobsen, I Cleynen, P S Andersen, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2013
Letter: dry blood spots for anti-TNF treatment monitoring in IBDN Vande Casteele, S Brecx, P Declerck, et al.
Gastroenterology|March 7, 2001
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosomeS Vermeire, J Satsangi, M Peeters, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2016
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experienceT Billiet, I Cleynen, V Ballet, et al.
The British Journal of Surgery|August 19, 2009
Outcome of surgery for rectovaginal fistula due to Crohn's diseaseC Ruffolo, F Penninckx, G Van Assche, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2011
Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assayN Vande Casteele, C Breynaert, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2004
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximabM Pierik, S Vermeire, K V Steen, et al.
Journal of Crohn'S & Colitis|August 18, 2021
Non-conventional Versus Conventional Strictureplasties for Crohn's Disease. A Systematic Review and Meta-analysis of Treatment OutcomesG Bislenghi, F Sucameli, S Fieuws, et al.
Scandinavian Journal of Gastroenterology|May 13, 2023
Managing metastatic Crohn's disease: a single center experience, review of the current evidence, and treatment algorithmS Beysens, J Wellens, G De Hertogh, et al.
Human Genetics|May 17, 2001
Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel diseaseA Rector, S Vermeire, I Thoelen, et al.
Pageof 14